Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I et al. Haematologica. 2006 Aug;91(8):1076-83. PMID:16885048 https://www.ncbi.nlm.nih.gov/pubmed/16885048 Like Tweet +1